ARTIVION, INC.
美股 AORT正常交易Artivion, Inc. ("Artivion," the "Company," "we," or "us"), is a leader in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. We have four major product families: aortic stent grafts, On-X mechanical heart valves and related surgical products ("On-X" products), surgical sealants, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts.
26.57 USD
▲ 1.53%更新于 2026-08-07 16:00:03(北京时间)
行情来源:新浪财经
- 行业
- 医疗器械
- 交易所/板块
- 纽交所
- CIK(SEC)
- 0000784199
- 国家/注册地
- 美国
- 上市日期
- 1993-02-11
- 事件总数
- 955
- 最新事件
- 2026-08-07
公司档案来源:SEC EDGAR(申报文件/公司信息)· 新浪财经(行情/中文名)
FORM TYPE
Showing 100 of 955